Genetic Biomarkers of Panic Disorder: A Systematic Review

Genes (Basel). 2020 Nov 4;11(11):1310. doi: 10.3390/genes11111310.

Abstract

(1) Background: Although panic disorder (PD) is one of the most common anxiety disorders severely impacting quality of life, no effective genetic testing exists; known data on possible genetic biomarkers is often scattered and unsystematic which complicates further studies. (2) Methods: We used PathwayStudio 12.3 (Elsivier, Netherlands) to acquire literature data for further manual review and analysis. 229 articles were extracted, 55 articles reporting associations, and 32 articles reporting no associations were finally selected. (3) Results: We provide exhaustive information on genetic biomarkers associated with PD known in the scientific literature. Data is presented in two tables. Genes COMT and SLC6A4 may be considered the most promising for PD diagnostic to date. (4) Conclusions: This review illustrates current progress in association studies of PD and may indicate possible molecular mechanisms of its pathogenesis. This is a possible basis for data analysis, novel experimental studies, or developing test systems and personalized treatment approaches.

Keywords: anxiety disorders; genetic biomarker; panic disorder.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Anxiety Disorders / genetics
  • Anxiety Disorders / metabolism
  • Biomarkers
  • Catechol O-Methyltransferase / genetics
  • Genetic Markers / genetics
  • Genetic Testing / methods
  • Humans
  • Panic Disorder / diagnosis
  • Panic Disorder / genetics*
  • Panic Disorder / metabolism
  • Serotonin Plasma Membrane Transport Proteins / genetics

Substances

  • Biomarkers
  • Genetic Markers
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • COMT protein, human
  • Catechol O-Methyltransferase